Am. J. Physiol. 224(4): 74-O-745. 1973 .-The hepatic regulation of plasma L-asparagine (Asn) was studied in isolated perfused rat livers. The Asn concentration in the perfusate is rigorously maintained by this organ at 20 PM. Attempts to deplete tissue Asn, normally 500 nmoles/g, by four 1 -hr perfusions with Asn-free perfusate (100 ml) resulted in increased tissue levels (25 %) and did not reduce the continuous contribution of Asn to the perfusate. Inhibition of Asn biosynthesis with 6-diazo-5-oxo-L-norleucine (DON) (10 mu) did not affect the regulation of the perfusate Asn concentration but permitted depletion of tissue Asn to 72 and 42y0 of control levels after two and four I-hr perfusions, respectively. Conversion of aspartic acid -14C to Asn occurred when livers were perfused with Asn-free perfusate or 20 m Asn but not with 200 PM Asn or 10 mu DON. 2,4-Dinitrophenol (0.5 mu) and substitution of choline for Na+ in the perfusate inhibited the influx of Asn by the liver but did not reduce the release of Asn into the perfusate. Thus, de novo Asn synthesis in rat liver is regulated by the concentration of Asn in the perfusate. Asparagine synthetase plays an important role in maintaining the hepatic Asn pool but does not function directly in the exchange of Asn with the perfusate. The latter process appears to involve both active and passive transport mechanisms which, together with Asn synthesis and metabolism, rigorously maintain constant Asn levels in the hepatic and plasma pools.
L-aspartic acid; L-glutamine; mammalian liver; active transport NUMEROUS REPORTS regarding the biological control of plasma levels of amino acids have appeared in the literature (1, 12, 14, 15, 19, 21, 28) . F ew, however, have been directly concerned with the regulation of plasma L-asparagine (Asn) in mammals.
The widespread occurrence of this amino acid in the blood and tissues (4, 5, 9, 10, 22) Radioassay of Am-W and Asp-l4c. The procedure for the determination of Asn-f4C and Asp-W (11) was derived from the coupled enzymatic assay described above and was modified for use in these studies. The two-stage procedure is based on the Znff -catalyzed decarboxylation of oxaloacetate formed from Asp-W after addition of GOT and, subsequently, from Asn -W after hydrolysis to Asp-W with L-asparaginase.
The amount of radioactivitv in each amino acid& wal determined sequentially by assaying the WO2 released after incubation of the perfusate sample with each enzyme.
Reactions took place in closed plastic liquid scintillation counting vials. Plastic caps from l8-gauge needle cartridges served as CO2 traps. Each cap contained 200 ~1 10 % NaOH and was fixed to the shaft of an l8-gauge needle which was fitted through the lid of each counting vial. Reactions were started by injecting the GOT mixture or L-asparaginase into the vial via the needle by means of a syringe. A cork was immediately placed in the syringe hub of the needle to prevent escape of the CO2 .
The GOT reaction mixture was prepared by adding 1.5 ml 70% &SO4 solution, 1 ml GOT (10 mg/ml), and 60 mg a-ketoglutaric acid to 13 ml 1 .O M acetate buffer, pH 5.6. Asp-W in 0.1 ml perfusate was determined after incubation with 2.9 ml 0.05 M Tris buffer, pH 7.5, 0.5 ml 1.0 M acetate buffer, pH 5.6, and 0.5 ml GOT mixture with shaking for 2.5 hr at 37 C. 
RESULTS
In a previous report from this laboratory (3 l), isolated perfused rat livers were shown to maintain rigorously the Asn concentration in the perfusate at 20 PM. The hepatic contribution of Asn to the perfusate suggested that asparagine synthetase in this organ might participate directly in this control.
This hypothesis was tested both in vivo and in vitro by administration of agents known to block Asn synthesis in various tissue preparations (7, 10, 13, 22, 24) . In in vivo experiments, rats were treated by intraperitoneal injection with CONV (100 mg/kg), DONV (100 mg/kg), or DON ( 10 "g/kg).
Blood samples were taken from the carotid artery at l-and 2hr intervals after injection for Asn assay. No deviation from plasma Asn levels observed in untreated rats could be detected in any case. Livers isolated from treated rats and perfused in the presence of
Asn to the perfusate in the same manner as occurred in untreated livers. These results suggested that Asn could be supplied to the perfusate from tissue pools for finite periods independent of de novo synthesis involving Asn synthetase. This possibility was explored by attempting to deplete the hepatic pool of Asn, normally 500 nmoles/g, by perfusing livers with sufficient Asn-free perfusate to remove all the Asn present in the liver pool. This attempted depletion of tissue Asn was performed both while Asn synthesis was permitted to occur and while it was blocked with DON. Since the liver contributes up to 2,000 nmoles/hr to the perfusate, four consecutive 1 -hr perfusions with 100 ml of Asn-free medium were performed to remove 8,000 nmoles of Asn from the liver, an amount in excess of that initially present in a 15-g liver. Figure 1 When DON ( 10 mM) was added to the Asn-free perfusate, the hepatic pool of Asn was reduced to 72 % of control after two 1 -hr perfusions and 42 % of control after four 1 -hr perfusions.
These results are demonstrated in Fig. 2 Asp (27 nmoles, 5 PC) was added to 100 ml of perfusate and the livers perfused for 1 hr. Figure 3 demonstrates that when livers were perfused with an Asn-free medium, the specific activity of Asn appearing in the perfusate was 3-5 times that observed when livers were perfused with 20 PM Asn, the equilibrium level. The recovery of specific activity of Asn was very markedly reduced when livers were perfused with medium initially 200 ,UM with respect to Asn.
Calculation of the rate of Asn synthesis is difficult over prolonged periods since the specific activity of the precursor Asp pool in the liver is constantly changing. However, initial synthesis rates were determined after 5 min, at which time dilution by entrance of perfusate Asn into the hepatic pool as Asp, consequent to indigenous asparaginase activity, was minimal.
Based on a hepatic Asp pool of 9,000 nmoles (600 nmoles/g X 15 g) plus 3,000 nmoles of Asp derived from Asn when livers were perfused with 200 PM Asn ( 15 % hydrolysis), the net synthesis over a 5-min period was 255 nmoles with 0 PM Asn. Similar calculations gave 31 nmoles with 20 PM Asn and less than 15 nmoles when the perfusate contained 200 PM Asn. The rate of synthesis as calculated could account for more than 50 % of the Asn contributed to the perfusate when it initially contained no Asn. These calculations are based on a rapid equilibration between perfusate and liver pools of aspartate, as demonstrated in the previous paper (3 1). They do not account for the endogenous turnover of the Asp pool in the liver during this 5-min period, a factor which gives a minimal rate of synthesis as calculated. Similar calculations made after 30 and 60 min of perfusion consistently indicate more rapid synthesis when the perfusate contained no Asn, but less marked differences are noted since the system is anproaching equilibrium. Asp when livers were perfused with Asn-free medium in the presence or absence of DON (Fig. 3) Fig. 4 . In these experiments liver donors were treated 1 hr prior to sacrifice by intraperitoneal injection of 25 mg/kg DNP suspended in isotonic saline solution at pH 9.0. Livers were perfused initially with Asn-free medium containing DNP (0.5 mM). After 1 hr, the Asn concentration was adjusted to 100 FM, and the effect of DNP on the hepatic uptake of Asn was observed. DNP did not appear to inhibit the rate or magnitude of Asn release by the liver. Treated livers did not differ significantly from controls in their capacity to establish a steady-state Asn concentration of 20 PM in the perfusate. However, the rate of removal of excess Asn from the perfusate was inhibited by approximately 50 % in the DNP-treated livers. These results indicate that the hepatic uptake of Asn involves a mechanism which is highly dependent on an energy source that is inhibited by DNP. The mechanism for the efflux of Asn does not appear to have such a requirement.
Since the transport of several amino acids has been shown to be coupled with Na+ transport, the effect of replacing Naf in the perfusate with choline was tested (Fig. 5A) . Asn uptake was almost totally prevented in the absence of Naf ion. The release of Asn by the liver, however, was not inhibited under these circumstances.
Figure 5B demonstrates that livers perfused with perfusate containing either 0 or 20 PM Asn released Asn to the Na+-free medium.
The magnitude of Asn efflux during perfusion with Asn-free medium was greater than that observed for controls, and a steady-state level was not achieved. These experiments indicate that Na+ is required for normal Asn concentration by the liver. Substitution of choline for Na+ results in complete inhibition of Asn uptake and causes Asn release to appear as passive diffusion.
The stereospecificity of Asn uptake was tested by perfusing livers with medium which was adjusted to 100 PM with respect to both L-Asn and D-Asn. The uptake of L-Asn occurred at the same rate and magnitude observed when L-Asn was present alone. The structural specificity of Asn uptake was indicated by the lack of competition of ~-Asp ( 100 PM) or L-Gln (300 PM) with the influx of L-Asn initially present at 100 PM.
DISCUSSION
These studies have extended previous findings concerning the regulation of plasma Asn levels by the isolated perfused rat liver (3 1). A model incorporating the basic elements of these findings is shown in Fig. 6 . Plasma and hepatic Asn pools are normally maintained at constant levels. Similar observations have been made with regard to Asp, although the hepatic pool of this amino acid appears to be somewhat more variable than that of Asn. Furthermore, plasma Asp is observed to be less rigorously regulated by the liver than is Asn. These facts might be expected in view of the more direct role played by Asp in intermediary metabolism (19, 30 Studies of the formation of Asn from radioactive Asp suggest that Asn synthetase in rat liver may be susceptible to regulation by Asn. Product inhibition of this enzyme in isolated cells or cell-free extracts has been reported (6, 24), and an increase in activity has been observed in response to treatment with L-asparaginase (26), feeding a diet deficient in Asn, or the rapid growth of an Asn-dependent tumor (25). It appears from these studies that Asn synthetase in rat liver is primarily responsive to changes in the concentration of Asn in the circulating medium rather than to alterations of the amino acid in the hepatic pool. The studies of the exchange of Asn with the perfusing medium show that an active transport mechanism is involved in hepatic Asn uptake. An energy-dependent carrier-mediated influx of amino acids has been described for a variety of mammalian organs (2, 3, 7, 16, 27, 29) . The current studies describe a system which appears to be relatively specific for Asn. 
